Schizophrenia & Psychotic Disorders

As many as one-quarter of suicide attempts are associated with psychotic experiences, according to a systematic review and meta-analysis published online in JAMA Psychiatry.


Higher peripheral neutrophil counts are associated with reduced gray matter, enlarged ventricles and more severe symptomatology in patients with first-episode psychosis (FEP), researchers report.

Anticipate some significant changes in the treatment of schizophrenia over the next 10 years, from a move toward coordinated specialty care to harnessing the power of social media to help identify symptoms sooner, said John M. Kane, MD, who will speak on the topic at the upcoming Psych Congress.

Cannabis use by mothers or fathers during pregnancy, or even only before pregnancy, is associated with an increased risk of psychotic-like episodes in their children, a Dutch study suggests.

The US Food and Drug Administration (FDA) has approved Perseris, the first monthly subcutaneous long-acting injectable containing risperidone, for the treatment of schizophrenia in adults, drugmaker Indivior PLC announced.

Psychotic experiences before age 13 are markers of increased risk for such disordered-eating behaviors as binge eating, fasting and purging in late adolescence, according to a new U.K. study.



Daisy Ng-Mak, PhD; Andrew Messali, PharmD, PhD; Krithika Rajagopalan, PhD; Joseph Tkacz, MS; Brenna L. Brady, PhD; Charles Ruetsch, PhD; Antony Loebel, MD
John M. Kane, MD; Christoph U. Correll, MD; Nick Delva, MD; Srihari Gopal, MD; Adam Savitz, MD; Maju Mathews, MD
Karen Anderson, MD; Mat Davis, PhD; Stewart Factor, DO; Robert Hauser, MD, MBA; Lars Jarskog, MD; Joohi Jimenez-Shahed, MD; Rajeev Kumar, MD, FRCPC; Stanislaw Ochudlo, MD, PhD; William Ondo, MD; Hubert Fernandez, MD
Branislav Mancevski, MD; Jagadish Gogate, PhD; Katie Ashcroft, BA, M.Phil D.Clin.Psy; Kristy Tardieu, BSN, MBA; Edward Kim, MD
Willie Earley, MD; Hua Guo, PhD; Balázs Szatmár, MD; György Németh, MD, PhD; Henry Nasrallah, MD; David Daniel, MD; Mehul Patel, PharmD; Chris Gache, MD



Peter Weiden, MD, and Charles Raision, MD, talk about how to do cognitive behavioral therapy with a group of people who have patterns of cognitive dysfunction. Click here to read the

Mary Anne Lang, MS, RN-BC, talks with Vladimir Maletic, MD, about practical ways to objectively track patients' adherence to antipsychotic medications.